Skip to main content
SpringerLink
Log in

Advances in the development of immunosuppressive agents in organ transplantation

  • Editorials
  • Published:
Surgery Today Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cecka JM, Terasaki PI (1992) The UNOS scientific renal transplant registry. In: Terasaki PI, Cecka JM (eds) Clinical transplants. UCLA Tissue Typing Laboratory, Los Angeles, pp. 1–16

    Google Scholar 

  2. Gjertson DW, Takemoto S, Cecka JM, Terasaki PI (1995) Impact of allocating cadaveric kidneys solely to “Centers of Excellence” versus by HLA matching. Transplant Proc 27:653–655

    CAS  PubMed  Google Scholar 

  3. Iwasaki Y, Amemiya H, Uchiyama G, Hanaoka T, Odaka M, Kamiya K (1974) Post-operative care and clinical results. In: Iwasaki Y (ed) Cadaveric renal transplantation. Igakushoin, Tokyo, pp 79–99

    Google Scholar 

  4. Amlot Pl, Rawlings E, Fernando ON, Griffin PJ, Heinrich G, Schreier MH, Castange JP, Moore R, Sweny P (1995) Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation. Transplantation 60:748–756

    CAS  PubMed  Google Scholar 

  5. Murray JE (1991) The first successful organ transplants in man. In: Terasaki PI (ed) History of Transplantation. UCLA Tissue Typing Laboratory, Los Angeles, pp 123–143

    Google Scholar 

  6. Merrill JP, Murray JE, Harrison JH (1956) Successful homotransplantation of the human kidney between identical twins. JAMA 160:277–282

    CAS  Google Scholar 

  7. Calne RY (1961) Inhibition of the rejection of renal homografts in dogs by purine analogues. Transplant Bull 26:65–81

    Google Scholar 

  8. Zukoski CF, Lee HM, Hume DM (1960) The prolongation of functional survival of canine renal homografts by 6-MP. Surg Forum 11:470–472

    CAS  PubMed  Google Scholar 

  9. Calne R (1991) Recollections from the laboratory to the clinic. In: Terasaki PI (ed) History of transplantation. UCLA Tissue Typing Laboratory, Los Angeles, pp 229–243

    Google Scholar 

  10. Calne RY, Murray JE (1961) Inhibition of the rejection of renal homografts in dogs by Burroughs Wellcome 57-222. Surg Forum 12:118

    CAS  PubMed  Google Scholar 

  11. Murray JE, Merrill JP, Harrison JH (1963) Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 268:1315–1323

    CAS  PubMed  Google Scholar 

  12. Merrill JP, Murray JE, Takacs F (1963) Successful transplantation of kidney from a human cadaver. JAMA 185:347–353

    CAS  PubMed  Google Scholar 

  13. Goodwin WE, Kaufman JJ, Mims MM (1963) Human renal transplantation. J Urol 89:13–24

    CAS  PubMed  Google Scholar 

  14. Starzl TE, Marchioro TL, Waddel WR (1963) The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 117: 385–395

    CAS  PubMed  Google Scholar 

  15. Murray JE, Barnes BA, Atkinson JC (1967) Fifth report of the human kidney transplant registry. Transplantation 5:752–774

    CAS  PubMed  Google Scholar 

  16. Starzl TE, Marchioro TL, Von Kaulla KN, Hermann G, Brittain RS, Waddell WR (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117:659–676

    CAS  PubMed  Google Scholar 

  17. Hardy JD, Webb WR, Dalton ML Jr, Walker GR (1963) Lung homotransplantation in man. JAMA 186:1065–1074

    CAS  PubMed  Google Scholar 

  18. Lillehei RC, Idezuki Y, Feemster JA, Dietzman RH, Kelly WD, Merkel FK, Goetz FC, Lyons GW, Manax WG (1967) Transplantation of stomach, intestine and pancreas. Surgery 62:721–741

    CAS  PubMed  Google Scholar 

  19. Barnard CN (1968) What we have learned about heart transplants. J Thorac Cardiovasc Surg 56:457–468

    CAS  PubMed  Google Scholar 

  20. Iwasaki Y, Takahashi H, Odaka M, Uematsu S, Ohkawa H, Amemiya H, Yokoyama K, Sato H (1969) Clinical application of orthotopic hepatic allografting (in Japanese). Geka 31:1381–1389

    Google Scholar 

  21. Ogoshi S, Okamura T (1974) Selection of cadaveric donor. In: Iwasaki Y (ed) Cadaveric renal transplantation. Igakushoin, Tokyo, pp 4–13

    Google Scholar 

  22. Belzer FO (1994) Kidney. In: History of the American Society of Transplant Surgeons. Stanton, Minneapolis, pp 235–248

    Google Scholar 

  23. Starzl TE, Koep L, Porter KA, Schroter GPJ, Weil III R, Hartley RB, Halgrimson CG (1980) Decline in survival after liver transplantation. Arch Surg 115:815–819

    CAS  PubMed  Google Scholar 

  24. Iwasaki Y, Porter KA, Amend JR, Marchioro TL, Zuhlke V, Starzl TE (1967) The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet 124:1–24

    CAS  PubMed  Google Scholar 

  25. Starzl TE, Porter KA (1968) Antilymphocyte globulins. In: Rappaport FT, Dausset J (eds) Human transplantation. Grune & Stratton, New York, pp 489–498

    Google Scholar 

  26. Cosimi AB, Wortis HH, Delmonico FL, Russel PS (1976) Randomized clinical trial of antilymphocyte globulin in cadaver renal allograft recipients. Surgery 80:155–163

    CAS  PubMed  Google Scholar 

  27. Ochiai T, Asano T, Sato H, Kashiwagi N, Fukao K, Amemiya H, Ohtsubo O, Taguchi Y, Kashiwabara H (1982) Results of multiinstitutional controlled study of ALG (in Japanese). Ishoku 17:391–400

    Google Scholar 

  28. Ochiai T, Ahmed A, Strong DM, Scher I, Sell KW (1975) Specificity and immuno-suppressive potency of a rabbit anti-mouse T cell specific antiserum. Transplantation 20:198–210

    CAS  PubMed  Google Scholar 

  29. Cosimi AB, Burton RC, Colvin RB (1981) Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 32:535–539

    CAS  PubMed  Google Scholar 

  30. Cecka M, Cicciarelli J (1985) The transfusion effect. In: Terasaki P (ed) Clinical kidney transplant. UCLA Tissue Typing Laboratory, Los Angeles, pp 73–92

    Google Scholar 

  31. Ochiai T, Gunji Y, Nagata M, Isono K (1983) Cyclosporine enhances an effect of donor-specific blood transfusion in canine renal transplantation. Transplant Proc 156:2939–2941

    Google Scholar 

  32. Borel JF (1982) The history of Cyclosporine A and its significance. In: White DJG (ed) Cyclosporine A. Elsevier, Amsterdam, pp 5–17

    Google Scholar 

  33. Borel JF, Baumann G, Chapman I (1996) In vivo pharmacological effects of cyclosporine and some analogues. Adv Pharmacol 35:115–246

    CAS  PubMed  Google Scholar 

  34. Calne RY, White DJG, Rolles K (1978) Prolonged survival of pig or orthotopic heart grafts treated with cyclosporine. Lancet 1:1183–1185

    CAS  PubMed  Google Scholar 

  35. Calne RY, White DJG, Thiru S (1978) Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet 2:1323–1327

    CAS  PubMed  Google Scholar 

  36. Starzl TE, Iwatsuki S, Shaw BW, Gordon RD (1986) Liver transplantation in the Cyclosporine era. Prog Allergy 38:366–394

    CAS  PubMed  Google Scholar 

  37. Ochiai T, Toma H, Takagi H, Oka T, Ishibashi M, Kashiwabara H, Ota K, Hashimoto I, Sonoda T, Iwasaki Y (1987) Japanese multicenter trial of Cyclosporine in renal transplantation. Transplant Proc 19:2961–2966

    CAS  PubMed  Google Scholar 

  38. Kino T, Hatanaka H, Miyata S, Inamura N, Yajima T, Goto T, Okuhara M, Kosaka M, Aoki H, Ochiai T (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. J Antibiot 40:1256–1265

    CAS  PubMed  Google Scholar 

  39. Ochiai T, Nagata M, Nakajima K, Suzuki T, Sakamoto K, Nakagohri T, Asano T, Isono K, Hamaguchi K, Goto T (1987) Studies on the effects of FK506 on renal allografting in the beagle dog. Transplantation 44:723–733

    Google Scholar 

  40. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K (1987) Studies on the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation of rats. Transplantation 44:734–738

    CAS  PubMed  Google Scholar 

  41. Todo S, Podesta L, ChapChap P (1987) Orthotopic liver transplantation in dogs receiving FK506. Transplant Proc 19 Suppl 6:64–67

    CAS  PubMed  Google Scholar 

  42. Lim SML, Thiru S, White DJG (1987) Heterotopic heart transplantation in the rat receiving FK506. Transplant Proc 19 Suppl 6:68–70

    CAS  PubMed  Google Scholar 

  43. Todo S, Ueda Y, Demetris JA (1988) Immunosuppression of canine, monkey, and baboon allografts by FK506. Surgery 104:239–249

    CAS  PubMed  Google Scholar 

  44. Starzl TE, Todo S, Fung J (1989) FK506 for liver, kidney and pancreas transplantation. Lancet 2:1000–1004

    CAS  PubMed  Google Scholar 

  45. Inamoto T, Nishizawa F, Sasaki H, Tanaka K, Yamaoka Y (1996) Experience of 120 microsurgical reconstructions of hepatic artery in living related liver transplantation. Surgery 119:20–26

    Google Scholar 

  46. Ochiai T, Ishibashi M, Fukao K, Takahashi K, Endo T, Yokoyama I, Uchida K, Ohshima S, Takahara S, Morozumi K, Yamaguchi Y, Kyo M, Sonoda T, Takagi H, Oka K, Iwasaki Y (1995) Japanese multicenter studies of FK506 in renal transplantation. Transplant Proc 27:50–53

    CAS  PubMed  Google Scholar 

  47. Sehgal SN, Baker H, Vezina C (1975) Rapamycin, a new antifungal antibiotic. J Antibiot 28:721–726

    PubMed  Google Scholar 

  48. Martel RR, Klicius J, Galet S (1977) Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 55:48–51

    CAS  PubMed  Google Scholar 

  49. Hollander GA, Bierer BE, Burakoff SJ (1996) Molecular mechanisms of immunosuppressive drugs: Cyclosporine A, FK506 and Rapamycin. In: Tilney NL, Strom TB, Paul LC (eds) Transplantation biology. Lippincott-Raven, Philadelphia, pp 657–671

    Google Scholar 

  50. Calne RY, Collier D St J, Lims (1989) Rapamycin for immunosuppression in organ allografting. Lancet 2:227

    CAS  PubMed  Google Scholar 

  51. Ochiai T, Gunji Y, Nagata M, Isono K (1993) Effects of Rapamycin in experimental organ transplantation. Transplantation 56:15–19

    CAS  PubMed  Google Scholar 

  52. Morris RE (1992) Rapamycins: antifungal, antitumor, antiproliferative and immunosuppressive macrolides. Transplant Rev 6:39–87

    Google Scholar 

  53. Fruman DA, Burakoff SJ, Bierer BF (1994) Molecular actions of Cyclosporine A, FK506 and Rapamycin. In: Thomson AW, Starzl TE (eds) Immunosuppressive drugs. Edward Arnold, London, pp 15–35

    Google Scholar 

  54. Schreiber SL (1991) Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251:283–287

    CAS  PubMed  Google Scholar 

  55. Schreiber SL, Crabtree GR (1992) The mechanisms of action of Cyclosporine A and FK506. Immunol Today 13:136–142

    Article  CAS  PubMed  Google Scholar 

  56. Rao R (1994) NF-A Tp: A transcription factor required for the coordinate induction of several cytokine genes. Immunol Today 15:274–281

    Article  CAS  PubMed  Google Scholar 

  57. Taniguchi M, Minami Y (1993) The IL-2/IL-2 receptor system. Cell 73:5–8

    Article  CAS  PubMed  Google Scholar 

  58. Fruman DA, Burakoff SJ, Bierer BE (1994) Immunophilins in protein folding and immunosuppression. FASEB J 8:391–400

    CAS  PubMed  Google Scholar 

  59. Sigal NH, Dumont F, Durette P, Siekerka JJ, Peterson L, Rich DH (1991) Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of Cyclosporine A? J Exp Med 172:619–628

    Google Scholar 

  60. Chiu MI, Katz H, Berlin V (1994) A mammalian homologue of yeast TOR interacts directly with the FKBP 12/rapamycin complex. Proc Natl Acad Sci USA 91:12574–12578

    CAS  PubMed  Google Scholar 

  61. Todo S, Fung JJ, Starzl TE (1994) Single-center experience with primary orthotopic liver transplantation with FK506 immunosuppression. Ann Surg 220:297–309

    CAS  PubMed  Google Scholar 

  62. The US multicenter FK506 liver study group (1994) A comparison of Tacrolimus and Cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331:1110–1115

    Google Scholar 

  63. Williams R, Neuhaus P, Bismuth H (1996) Two-year data from the European multicenter Tacrolimus liver study. Transpl Int 9 Suppl 1:s144-s150

    CAS  PubMed  Google Scholar 

  64. Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J (1996) A multicenter trial of FK506 therapy in refractory acute renal allograft rejection. Transplantation 62:594–599

    CAS  PubMed  Google Scholar 

  65. van Hoff J, The European Tacrolimus Multicenter Renal Study Group (1996) The European multicenter prospective randomized trial comparing Tacrolimus and Cyclosporine in the prevention of renal allograft rejection. 16th International Congress of the Transplantation Society, Barcelona

  66. Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H, Satomura K, Kiuchi T, Yamaoka Y, Hashida T (1996) The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 61:247–252

    CAS  PubMed  Google Scholar 

  67. Uemoto S, Tanaka K, Honda K, Tokunaga Y, Sano K, Katoh H, Yamamoto E, Takada Y, Ozawa K (1993) Experience with FK506 in living-related liver transplantation. Transplantation 55:288–292

    CAS  PubMed  Google Scholar 

  68. Kahan BD, Pescovitz M, Julian B, Chan G, Vanrenterghem Y (1996) Multi-center Phase II trial of Sirolimus in renal transplantation. XVI International Congress of the Transplantation Society, Barcelona

  69. Gjertson M, Cecka JM, Terasaki PI (1995) The relative effects of FK506 and Cyclosporine on short and long term kidney graft survival. Transplantation 60:1384–1388

    CAS  PubMed  Google Scholar 

  70. Wang T, Donahue PK, Zervos AS (1994) Specific interaction of type I receptors of the TGF β family with the immunophilin FKBP12. Science 265:674–676

    CAS  PubMed  Google Scholar 

  71. Ahuja S, Shrivastav S, Daielpour D, Balow J (1995) Regulation of transforming growth factor-β and its receptor by cyclosporine in human T-lymphocytes. Transplantation 60:718–723

    CAS  PubMed  Google Scholar 

  72. Jutila MA (1994) Role of changes in the vascular endothelium in chronic inflammation. Clin Transpl 8:304–307

    CAS  Google Scholar 

  73. Lemster BH, Carroll PB, Rilo HR (1995) IL8/IL8 receptor expression in psoriasis and the response to systemic Tacrolimus therapy. Clin Exp Immunol 99:148–154

    CAS  PubMed  Google Scholar 

  74. Manez R, Jain A, Marino IR, Thomson AW (1995) Comparative evaluation of Tacrolimus (FK506) and Cyclosporine A as immunosuppressive agents. Transplant Rev 9(2):63–76

    Article  Google Scholar 

  75. Faulds D, Goa KI, Benfield P (1993) Cyclosporine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 45:953

    CAS  PubMed  Google Scholar 

  76. Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Starzl TE (1991) Adverse effects associated with the use of FK506. Transplant Proc 23:3105–3108

    CAS  PubMed  Google Scholar 

  77. Ochiai T, Sakamoto K, Gunji Y, Isono K (1989) Effects of combination treatment with FK506 and Cyclosporine on survival time and vascular changes is renalallograft recipient dogs. Transplantation 48:193–197

    CAS  PubMed  Google Scholar 

  78. Mueller EA, Kovarik JM, van Bree JB, Lison AE (1994) Safety and steady-state pharmacokinetics of a new oral formulation of Cyclosporine A in renal transplant patients. Transplant Int 7 Suppl 1:s267-s269

    Google Scholar 

  79. Polland SG, Lodge PJ, UK Neoral Renal Study Group (1996) Neoral vs Sandimmune: interim results of a randomized trial of efficacy and safety in preventing actue rejection in new renal transplant recipients. 16th International Congress of the Transplantation Society, Barcelona

  80. Ochiai T, Gunji Y, Nagata M, Isono K (1991) Effective and safe use of FK506: combination treatment with Rapamycin and RS-61443 in experimental organ transplantation. Transplant Proc 23:2718–2719

    CAS  PubMed  Google Scholar 

  81. Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Ythier A, Strom TB (1985) Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J Exp Med 162:358–362

    Article  CAS  PubMed  Google Scholar 

  82. Neuhaus P, Bechstein WO, Blumhardt G, Wiens M, Lemmens P, Langehr JM, Lohmann R, Steffen R, Schlag H, Slama KJ, Lobeck H (1993) Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation 55:1320–1327

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku, 260, Chiba, Japan

    Takenori Ochiai & Kaichi Isono

Authors
  1. Takenori Ochiai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaichi Isono
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ochiai, T., Isono, K. Advances in the development of immunosuppressive agents in organ transplantation. Surg Today 27, 883–891 (1997). https://doi.org/10.1007/BF02388134

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02388134

Search

Navigation